Literature DB >> 9040439

Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure.

H Murakami1, J L Liu, I H Zucker.   

Abstract

Enhanced sympathetic outflow is seen in both patients with congestive heart failure and animals with experimental heart failure. In a previous study, we demonstrated that the baroreflex control of heart rate was impaired in conscious rabbits with pacing-induced heart failure and that this impairment was partially restored by blockade of angiotensin II type 1 (AT1) receptors. In the present study, we determined the interaction between the renin-angiotensin system and baroreflex control of renal sympathetic nerve activity in normal conscious rabbits and conscious rabbits with pacing-induced heart failure before and after AT1 receptor blockade. Heart failure was induced by rapid ventricular pacing at a rate of 360 to 380 beats per minute for an average of 16.7 +/- 0.6 days. To generate baroreflex curves, we altered arterial pressure by administering phenylephrine and sodium nitroprusside. A sigmoidal logistic function was fit to renal sympathetic nerve activity-mean arterial pressure relationships for analysis of several components of baroreflex function. AT1 receptors were blocked by intravenous administration of the specific antagonist L-158,809. In normal rabbits, there was no significant difference in any parameter of baroreflex function before and after blockade of AT1 receptors. In contrast, blockade of AT1 receptors enhanced baroreflex sensitivity in heart failure rabbits. The maximal gain increased to 5.0 +/- 0.7% renal sympathetic nerve activity/mm Hg from 2.6 +/- 0.3 (P < .05). Although L-158,809 had no effect on baseline renal sympathetic nerve activity in normal rabbits, analysis of the data in the heart failure rabbits indicated that baseline renal sympathetic nerve activity was reduced from 33 +/- 5% to 17 +/- 4% after L-158,809 administration after adjustment for changes in arterial pressure. These data suggest that angiotensin II plays a role in baroreflex impairment in this model of heart failure and may be in part responsible for the depressed baroreflex sensitivity observed in heart failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040439     DOI: 10.1161/01.hyp.29.2.564

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

Review 1.  Pregnancy and the endocrine regulation of the baroreceptor reflex.

Authors:  Virginia L Brooks; Roger A L Dampney; Cheryl M Heesch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-26       Impact factor: 3.619

2.  Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure.

Authors:  Rohit Ramchandra; Sally G Hood; Anna M D Watson; Andrew M Allen; Clive N May
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

Review 3.  Organ selective regulation of sympathetic outflow by the brain Angiotensin system.

Authors:  Rohit Ramchandra; Song T Yao; Clive N May
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 4.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

5.  Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.

Authors:  Rohit Ramchandra; Anna M D Watson; Sally G Hood; Clive N May
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

6.  Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons.

Authors:  Dongmei Liu; Lie Gao; Shyamal K Roy; Kurtis G Cornish; Irving H Zucker
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

Review 7.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

Review 8.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

9.  Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure.

Authors:  Rohit Ramchandra; Sally G Hood; Derek A Denton; Robin L Woods; Michael J McKinley; Robin M McAllen; Clive N May
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

10.  Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.

Authors:  George Suzuki; Takayuki Mishima; Elaine J Tanhehco; Victor G Sharov; Anastassia Todor; Sharad Rostogi; Ramesh C Gupta; Pervaiz A Chaudhry; Petros V Anagnostopoulos; Omar Nass; Sidney Goldstein; Hani N Sabbah
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.